...
机译:将组蛋白脱乙酰酶活性阻断为过敏性鼻炎患者上皮阻挡缺陷的新靶标
Katholieke Univ Leuven Dept Microbiol Immunol &
Transplantat Allergy &
Clin Immunol Res Grp;
Univ Zurich Swiss Inst Allergy &
Asthma Res SIAF Davos Switzerland;
Katholieke Univ Leuven Dept Microbiol Immunol &
Transplantat Allergy &
Clin Immunol Res Grp;
Katholieke Univ Leuven Dept Microbiol Immunol &
Transplantat Allergy &
Clin Immunol Res Grp;
Katholieke Univ Leuven Dept Microbiol Immunol &
Transplantat Allergy &
Clin Immunol Res Grp;
Katholieke Univ Leuven Dept Microbiol Immunol &
Transplantat Allergy &
Clin Immunol Res Grp;
Katholieke Univ Leuven Dept Microbiol Immunol &
Transplantat Allergy &
Clin Immunol Res Grp;
Katholieke Univ Leuven Lab Environm &
Hlth Dept Publ Hlth &
Primary Care Leuven Belgium;
Univ Zurich Swiss Inst Allergy &
Asthma Res SIAF Davos Switzerland;
Univ Zurich Swiss Inst Allergy &
Asthma Res SIAF Davos Switzerland;
Univ Zurich Swiss Inst Allergy &
Asthma Res SIAF Davos Switzerland;
Katholieke Univ Leuven Dept Microbiol Immunol &
Transplantat Allergy &
Clin Immunol Res Grp;
Allergic rhinitis; tight junctions; primary nasal epithelial cells; epigenetic changes; histone deacetylase;
机译:将组蛋白脱乙酰酶活性阻断为过敏性鼻炎患者上皮阻挡缺陷的新靶标
机译:过敏原机械屏障凝胶对过敏性鼻炎患者症状和生活质量的疗效
机译:miR-143通过靶向IL13R alpha 1抑制变应性鼻炎患者鼻上皮细胞中白介素13诱导的炎症细胞因子和黏液生成
机译:适用于患者过敏性鼻炎的线性判别分析
机译:P27作为癌症治疗的分子靶标:发现p27蛋白水解和结构活性关系的小分子抑制剂以及组蛋白脱乙酰基酶的有效抑制剂largazole的机理研究。
机译:原始文章:组蛋白脱乙酰基酶抑制剂曲古抑菌素A通过阻断2组先天性淋巴样细胞(ILC2)的激活来抑制鼠类先天性过敏性炎症
机译:靶向组蛋白脱乙酰酶以恢复上皮屏障完整性:过敏气道患者的个性化药物的新选择?